Trump admin says it will save $2.2 billion by kicking off 760,000 Affordable Care Act enrollees over fraud claims

The Trump administration plans to terminate roughly 315,000 ACA marketplace enrollments covering 760,000 people, citing suspected fraud or ineligibility, and estimates $2.2 billion in subsidy savings. Another 419,000 enrollments will face additional verification, while new enrollment agents and brokers will be suspended for six months. The move comes as ACA premiums have doubled or tripled for many participants following the expiration of COVID-era subsidies, increasing political and affordability pressure ahead of the fall midterm elections.

Analysis

The economically relevant exposure is concentrated in exchange-heavy carriers—Centene (CNC), Molina (MOH) and Oscar Health (OSCR)—rather than diversified managed care. Removing zero- or low-claims members reduces premium revenue roughly dollar-for-dollar with subsidies but can worsen reported medical-loss ratios because these members likely contributed premium with minimal utilization. The immediate valuation risk is therefore not just membership loss: a smaller, sicker residual risk pool raises the probability of 2027 rate increases, adverse risk-adjustment transfers and lower exchange-margin confidence.

The six-month broker restriction is potentially more consequential than the enrollment purge if it overlaps the 2027 open-enrollment acquisition cycle. EHealth (EHTH), GoHealth (GOCO), and unlisted agency/distribution networks face lower lead conversion and commission opportunity, while direct-to-consumer carriers such as OSCR could gain relative share only if CMS permits compliant direct enrollment channels to remain frictionless. A broader verification regime would also increase administrative cost per enrollee and create churn, making scale incumbents better positioned operationally but not necessarily more profitable if risk-pool quality deteriorates.

Consensus may overstate the fiscal significance and understate the political feedback loop. If affordability remains a salient election issue, enrollment disruption and premium pressure increase the odds of a targeted subsidy or stabilization response within 6-18 months; that would be more material for MOH/CNC/OSCR than the announced savings. The bearish carrier thesis is falsified if CMS publishes evidence that terminated members had above-average claims or if 2027 preliminary exchange filings show stable morbidity assumptions and no material risk-adjustment deterioration.

Key Decisions for Investors

• Maintain a 1-3 month underweight in OSCR versus ELV: OSCR has greater sensitivity to exchange enrollment, acquisition friction and risk-pool volatility, while ELV's earnings base is materially more diversified. Reassess if OSCR discloses stable retention and unchanged exchange contribution-margin guidance.
• Watch for a tactical long MOH / short OSCR pair after 2027 preliminary rate filings: MOH's scale and state-program infrastructure should absorb verification costs better, but only initiate if filings indicate morbidity deterioration is being priced into rates. Target 10-15% relative return; exit if CMS delays or narrows broker restrictions before open enrollment.
• Avoid treating CNC's headline membership reduction as automatically bullish for margins. Require disclosure of terminated-member claims experience, exchange medical-loss ratio and risk-adjustment assumptions at the next earnings release; absent that data, the correct stance is reduced exposure rather than a directional short.
• For EHTH and GOCO, set an event-driven downside alert around any CMS clarification on whether the suspension affects the coming open-enrollment period. A broad restriction through enrollment season would justify short exposure; a narrowly targeted enforcement action would remove the core thesis quickly.